Advertisement

Topics

Novimmune Sells Gamifant And IO Assets To Sobi

00:59 EDT 14 Jun 2019 | SCRIP

Swiss biotech Novimmune SA creates newco around Gamifant emapalumab and other immuno-oncology assets and then sells it to Sobi for...

      

Related Stories

 

Original Article: Novimmune Sells Gamifant And IO Assets To Sobi

NEXT ARTICLE

More From BioPortfolio on "Novimmune Sells Gamifant And IO Assets To Sobi"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...